Initial Data and a Clinical Diagnosis Transition for the Aiginition Longitudinal Biomarker Investigation of Neurodegeneration (ALBION) Study

Initial Data and a Clinical Diagnosis Transition for the Aiginition Longitudinal Biomarker Investigation of Neurodegeneration (ALBION) Study

<i>Background and Objectives: </i>This article presents data from the ongoing Aiginition Longitudinal Biomarker Investigation of Neurodegeneration study (ALBION) regarding baseline clinical characterizations and CSF biomarker profiles, as well as preliminary longitudinal data on clinical...

Full description

Bibliographic Details
Main Authors: Nikolaos Scarmeas, Argyro Daskalaki, Faidra Kalligerou, Eva Ntanasi, Eirini Mamalaki, Antonios N. Gargalionis, Kostas Patas, Stylianos Chatzipanagiotou, Mary Yannakoulia, Vasilios C. Constantinides
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Medicina
Subjects:
Alzheimer’s disease
biomarker
CSF biomarker
neurodegeneration
ALBION study
Online Access:https://www.mdpi.com/1648-9144/58/9/1179

Internet

https://www.mdpi.com/1648-9144/58/9/1179

Similar Items